The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online July 10, 2009
The Journal of Immunology, 2009, 183, 1617 -1624
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0804362

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0804362v1
183/3/1617    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hu, G.
Right arrow Articles by Chen, X.-M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, G.
Right arrow Articles by Chen, X.-M.

MicroRNA-98 and let-7 Confer Cholangiocyte Expression of Cytokine-Inducible Src Homology 2-Containing Protein in Response to Microbial Challenge1,2

Guoku Hu, Rui Zhou, Jun Liu, Ai-Yu Gong, Alex N. Eischeid, Jared W. Dittman and Xian-Ming Chen3

Department of Medical Microbiology and Immunology, Creighton University Medical Center, Omaha, NE 68178

Posttranscriptional gene regulation by microRNAs (miRNAs) has been implicated in the fine-tuning of TLR-mediated inflammatory response. The cytokine-inducible Src homology 2-containing protein (CIS), one member of the suppressors of cytokine signaling family of proteins, is an important negative regulator for inflammatory cytokine signaling. Using in vitro models using normal human biliary epithelial cells (cholangiocytes), we demonstrated that LPS stimulation or infection with the parasitic protozoan Cryptosporidium parvum induced expression of CIS protein without a change in CIS mRNA levels by activating the TLR signaling pathway. Of those miRNAs expressed in cholangiocytes, we found that targeting of the 3'-untranslated region of CIS by microRNA-98 (miR-98) or let-7 resulted in translational repression, but not CIS mRNA degradation. LPS stimulation or C. parvum infection decreased cholangiocyte expression of miR-98 and let-7. Down-regulation of miR-98 and let-7 relieved miRNA-mediated translational suppression of CIS and contributed to LPS- and C. parvum-stimulated CIS protein expression. Moreover, gain-of-function (by overexpression of CIS) and loss-of-function (by siRNA interference) studies revealed that CIS could enhance I{kappa}B{alpha} degradation and regulate NF-{kappa}B activation in cholangiocytes in response to LPS stimulation or C. parvum infection. Our data suggest that miR-98 and let-7 confer cholangiocyte expression of CIS in response to microbial challenge, a process that may be relevant to the regulation of TLR-mediated epithelial innate immune response.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants AI071321 and by the Nebraska Tobacco Settlement Biomedical Research Program LB692 (to X-M.C).

2 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

3 Address correspondence and reprint requests to Dr. Xian-Ming Chen, Department of Medical Microbiology and Immunology, Creighton University Medical Center, 2500 California Plaza, Omaha, NE 68178. E-mail address: xianmingchen{at}creighton.edu

4 Abbreviations used in this paper: CIS, cytokine-inducible Src homology 2-containing protein; SOCS, suppressors of cytokine signaling protein; SH, Src homology; miRNA, microRNA; UTR, untranslated region; HIBEpiC, human intrahepatic biliary epithelial; miR-98, microRNA-98; DN, dominant negative.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.